Status:
COMPLETED
Evaluating the Need for the Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
Lead Sponsor:
Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons
Conditions:
Cataract
Nuclear Sclerosis
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
To determine clinically significant difference in results obtained from cataract surgery using IA. One eye will receive aphakic measurements only and the fellow eye will receive aphakic and then pseud...
Detailed Description
To determine if there is a clinically significant difference in the results obtained for the toric IOL implantation when using IA to measure the aphakic eye only and when using IA to measure the aphak...
Eligibility Criteria
Inclusion
- willing and able to understand and sign an informed consent
- willing and able to attend all study visits
- presenting for uncomplicated bilateral cataract surgery and have an interest in a toric iol
- have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error)
- have visually significant cataracts
- have regular corneal astigmatism of 1.0D to 5.0D in both eyes with a difference between eyes of 1.0D or less
- have potential post operative acuity of 20/25 or better
Exclusion
- corneal pathology
- amblyopia
- prior corneal refractive surgery or other refractive surgery
- previous anterior or posterior chamber surgery that the investigator feels may compromise visual outcomes
- Diabetic retinopathy if the investigator feels this will compromise visual outcomes
- macular degeneration
- history of retinal detachment
- irregular astigmatism or keratoconus
- strabismus
- if in the surgeon's opinion the subject is not an appropriate candidate for iol implantation
- subjects who have an acute or chronic disease or illness that would confound the results of this investigation
Key Trial Info
Start Date :
March 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03819842
Start Date
March 19 2018
End Date
January 14 2019
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alterman Modi and Wolter Ophthalmic Physicians and Surgeons
Poughkeepsie, New York, United States, 12603